[18F]fluoroethoxy-benzovesamicol, a PET radiotracer for the vesicular acetylcholine transporter and cholinergic synapses

Synapse

Volumn 30, Issue 3, 1998, Pages 263-274

  Mulholland, G Keith ^a,b   Wieland, Donald M ^a   Kilbourn, Michael R ^a   Frey, Kirk A ^a   Sherman, Phillip S ^a   Carey, James E ^a   Kuhl, David E ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

Autoradiography; Cholinergic; Dosimetry; Imaging; PET; Synapse; Vesamicol

Indexed keywords

ACETYLCHOLINE; FLUOROETHOXYBENZOVESAMICOL F 18; TRACER; UNCLASSIFIED DRUG; CARRIER PROTEIN; CHOLINESTERASE INHIBITOR; DONEPEZIL; DOPAMINE RECEPTOR STIMULATING AGENT; FLUORINE; FLUOROETHOXY BENZOVESAMICOL; FLUOROETHOXY-BENZOVESAMICOL; HALOPERIDOL; INDAN DERIVATIVE; N-N-PROPYL-3-(3-HYDROXYPHENYL)PIPERIDINE; PIPERIDINE DERIVATIVE; PRECLAMOL; SLC18A3 PROTEIN, HUMAN; SLC18A3 PROTEIN, MOUSE; SLC18A3 PROTEIN, RAT; VESICULAR ACETYLCHOLINE TRANSPORTER; VESICULAR TRANSPORT PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; AUTORADIOGRAPHY; BRAIN MAPPING; CHOLINERGIC SYNAPSE; CHOLINERGIC TRANSMISSION; DOSIMETRY; FEMALE; ISOTOPE LABELING; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SYNAPSE VESICLE; ANIMAL; ANTIBODY SPECIFICITY; BRAIN; CALIBRATION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DRUG EFFECT; HUMAN; KINETICS; MALE; METABOLISM; METHODOLOGY; RAT; SPRAGUE DAWLEY RAT; STEREOISOMERISM; SYNAPSE; TISSUE DISTRIBUTION;

ACETYLCHOLINE; ANIMALS; AUTORADIOGRAPHY; BRAIN; CALIBRATION; CARRIER PROTEINS; CHOLINESTERASE INHIBITORS; DOPAMINE AGONISTS; FEMALE; FLUORINE RADIOISOTOPES; HALOPERIDOL; HUMANS; INDANS; KINETICS; MALE; MEMBRANE TRANSPORT PROTEINS; MICE; ORGAN SPECIFICITY; PIPERIDINES; RATS; RATS, SPRAGUE-DAWLEY; STEREOISOMERISM; SYNAPSES; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED; VESICULAR ACETYLCHOLINE TRANSPORT PROTEINS; VESICULAR TRANSPORT PROTEINS;

EID: 0031595258     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(199811)30:3<263::AID-SYN4>3.0.CO;2-9     Document Type: Article

References (64)

1. 3H]Vesamicol binding in brain: Autoradiographic distribution, pharmacology, and effects of cholinergic lesions. Synapse, 2:488-493.
2. Bekenstein, J.W., and Wooten, G.F. (1989) Hemicholinium-3 binding sites in rat brain: A quantitative autoradiographic study. Brain Res., 481:97-105.
3. Brennan, M.B. (1997) Bringing back the memories. Chem. Eng. News, 75:29-32.
4. Dannals, R.F., Ravert, H.T., Frost, J.J., Wilson, A.A., Burns, H.D., and Wagner, H.N. (1985) Radiosynthesis of an opiate binding radiotracer: [11C]carfentanil. Int. J. Appl. Radiat. Isot., 36:303-306.
5. Davies, C.A., Mann, D.M.A., Sumpter, P.W., and Yates, P.O. (1987) A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease. J. Neurol. Sci., 78:151-164.
6. Degrade, T.R., Mulholland, G.K., Wieland, D.M., and Schwaiger, M. (1994) Evaluation of (-) [18F]fluoroethoxybenzovesamicol as a new PET tracer of cholinergic neurons inthe heart. Nucl Med Biol. 21:189-195.
7. DeKosky, S.T., and Scheff, S.W. (1990) Synaptic loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity. Ann. Neurol., 27:457-464.
8. Ding, Y.-S., Gatley, S.J., Fowler, J.S., Volkow, N.D., Aggarrwal, D., Logan, J., Dewey, S.L., Liang, F., Carrol, F.I., and Kuhar, M.J. (1996) Mapping nicotinic acetylcholine receptors with PET. Synapse, 24: 403-407.
9. Efange, S.M.N., Dutta, A.K., Michelson, R.H., Kung, H.F., Thomas, J.R., Billings, J., and Boudreau, R.J. (1992) Radioiodinated 2-hydroxy-3-(iodophenyl)-1-(4-phenylpiperidinyl)propane: Potential radiotracer for mapping central cholinergic innervation in vivo. Nucl. Med. Biol., 19:337-348.
10. 125I]MIBT): Potential radioligand for mapping central cholinergic innervation. J. Med. Chem., 36:1754-1760.
11. 18F]FBT): Molecular decomposition-reconstitution approach to vesamicol receptor radioligands for positron emission tomography. Appl. Radiat. Isot., 45:465-472.
12. Efange, S.M.N., Khare, A.B., and Langason, R.B. (1995a) Comparative tissue distribution of conformationally restricted radioiodinated vesamicol receptor ligands. Nucl. Med. Biol., 22:437-444.
13. 125I]MIBT binding in human temporal cortex reveals hypofunction in Alzheimer's disease. J. Labelled Comp. Radiopharm., 37:376-377.
14. Efange, S.M.N., Langason, R.B., and Khare, A.B. (1996) Age related diminution of dopamine antagonist-stimulated vesamicol receptor binding. J. Nucl. Med., 37:1192-1197.
15. Erickson, J.D., Varoqui, H., Schafer, M.K.H., Modi, W., Dibler, M.F., Weihe, E., Rand, J., Eiden, L.E., Bonner, T.I., and Usdin, TB. (1994) Functional identification of a vesicular acetylcholine transporter and its expression from a "cholinergic" gene locus. J. Biol. Chem., 269:21929-21932.
16. Erickson, J.D., Weihe, E., Schafer, M.K.H., Neale, E., Williamson, L., Bonner, T.I., Cheng, J.H.T., and Eiden, L.E. (1996) The VAChT/ChaT "cholinergic gene locus": New aspects of genetic and vesicular regulation of cholinergic function. Prog. Brain Res., 109:69-82.
17. French, A.N., Napolitano, E., VanBrocklin, H.F., Hanson, R.N., Welch, M.J., and Katzenellenbogen, J.A. (1993) Synthesis, radiolabeling and tissue distribution of 11β-fluoroalkyl- and 11β-fluoroalkoxy-substituted estrogens: Target tissue uptake selectivity and defluorination of a homologous series of fluorine-18-labeled estrogens. Nucl. Med. Biol., 20:31-47.
18. Fuhrmann, G., Durkin, T., Thiriet, G., Kempf, E., and Ebel, A. (1985) Cholinergic neurotransmission in the central nervous system of the Snell dwarf mouse. J. Neurosci. Res., 13:417-430.
19. Gilmor, M.L., Nash, N.R., Roghani, A., Edwards, R.H., Yi, H., Hersh, S.M., and A.I., L. (1996) Expression of the putative vesicular acetylcholine transporter in rat brain and localization in cholinergic synaptic vesicles. J. Neurosci., 16:2179-2190.
20. Gilmor, M.J., Counts, S.C., Wiley, R.G., and Levey, A.I. (1997) Co-regulation of the vesicular acetylcholine transporter (VACHT) and choline acetyltransferase (CHAT) in septohippocampal pathway lesions. Soc. Neurosci. Abstr., 23:695.
21. Gomez-Isla, T., Hollister, R., West, H., et al. (1997) Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann. Neurol., 41:17-24.
22. 3H]hemicholinium-3 as a quantitative marker. J. Neurochem., 60:1191-1201.
23. Hicks, B.W., Rogers, G.A., and Parsons, S.M. (1991) Purification and characterization of nonvesicular vesamicol-binding protein from electric organ and demonstration of a related protein in mammalian brain. J. Neurochem., 57:509-519.
24. Horti, A., Scheffel, U., Stathis, M., Finley, P., Ravert, H.T., London, E.D., and Dannals, R.F. (1997) Fluorine-18 FPH for PET imaging of nicotinic acetylcholine receptors. J. Nucl. Med., 38:1260-1265.
25. Ingvar, M., Stone-Elander, S., Rogers, G.A., et al. (1993) Striatal acetylcholine interactions: PET studies of the vesamicol receptor. NeuroReport, 4:1311-1314.
26. Irie, T., Fukushi, K., Akimoto, Y.Tamagami, H., and Nozaki, T. (1994) Design and evaluation of radioactive acetylcholine analogs for mapping brain acetylcholinesterase (ACHE) in vivo. Nucl. Med. Biol., 21:801-808.
27. Itzhaki, R.F. (1994) Possible factors in the etiology of Alzheimers disease. Mol. Neurobiol., 9:1-13.
28. Jung, Y.-W., Van Dort, M.E., Gildersleeve, D.L., and Wieland, D.M. (1990) A radiotracer for mapping cholinergic neurons of the brain. J. Med. Chem., 33:2065-2068.
29. Jung, Y.-W., Frey, K.A., Mulholland, G.K., del Rosario, R., Sherman, P.S., Raffel, D.M., Van Dort, M.E., Kuhl, D.E., Gildersleeve, D.L., and Wieland, D.M. (1996) Vesamicol receptor mapping of brain cholinergic neurons with radioiodine-labeled positional isomers of benzovesamicol. J. Med. Chem., 39:3331-3342.
30. Kilbourn, M.R., Jung, Y.-W., Haka, M.S., Gildersleeve, D.L., Kuhl, D.E., and Wieland, D.M. (1990) Mouse brain distribution of a carbon-11 labeled vesamicol derivative: Presynaptic marker of cholinergic neurons. Life Sci., 47:1955-1963.
31. 11C]PMP). Synapse, 22:123-131.
32. 3H]Vesamicol binding in human brain cholinergic deficiency disorders. Neurosci. Lett., 117:347-352
33. 3H]3-(3-Hydroxyphenyl)-N-(1-propyl)piperidine binding to s receptors in mouse brain in vivo. Eur. J. Pharmacol., 161:263-266.
34. Koe, B.K., Fox, C.B., and Lebel, L.A. (1991) Structural classes of compounds with potent affinity for brain sigma binding sites. Soc. Neurosci. Abstr., 17:332.
35. Kuhl, D.E., Koeppe, R.A., Fessler, J.A., Minoshima, S., Ackerman, R.J., Carey, J.E., Gildersleeve, D.L., Frey, K.A., and Wieland, D.M. (1994) In vivo mapping of cholinergic neurons in the human brain using SPECT and IBVM. J. Nucl. Med., 35:405-410.
36. Kuhl, D.E., Minoshima, S., Fessler, J.A., Frey, K.A., Foster, N.L., Ficaro, E.P., Wieland, D.M., and Koeppe, R.A. (1996) In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease and Parkinson's disease. J. Ann. Neurol., 40:399-410.
37. Lehmann, J., and Langer, S.Z. (1983) The striatal cholinergic interneuron: Synaptic target of dopamine terminals? J. Neurosci., 10:1105-1120.
38. Loevinger, R., and Berman, M. (1976) A Revised Scheme for Calculating Absorbed Dose from Biologically Distributed Radionuclides, Vol. 1, Revised. Society of Nuclear Medicine, New York.
39. 18F](+)-4-fluorobenzyltrozamicol: In vitro binding studies and positron emission tomography studies in non-human primates. Synapse, 25:368-380.
40. Marien, M.R., Parsons, S.M., and Altar, C.A. (1987) Quantitative autoradiography of brain binding sites for the vesicular acetylcholine transport blocker2-(4-phenylpiperidino)cyclohexanol (AH5183). Proc. Natl. Acad. Sci. USA, 84:876-880.
41. Masliah, E., Miller, A., and Terry, R.D. (1992a) The synaptic organization of the neocortex in Alzheimer's disease. Med. Hypotheses, 41:334-340.
42. Masliah, E., Ellisman, M., Carragher, B., Mallory, M., et al. (1992b) Three dimensional analysis of the relationship between synaptic pathology and neuropil threads in Alzheimer's disease. J. Neuropath. Exp. Neurol., 51:404-414.
43. 18F]-fluorobenzyl-ABV: A new potential marker for central cholinergic presynaptic sites. J. Nucl. Med., 32:P994.
44. Mulholland, G.K., Sherman, P.S., Pisani, T.L., et al. (1991b) Effect of lipophilicity on brain uptake of labeled aminobenzovesamcols. Potential tracers for cholinergic neurons. J. Cereb. Blood. Flow Metab., 11:S622.
45. 11C]methylaminobenzovesamicol. J. Labelled Comp. Radiopharm., 31:253-259.
46. 18F]fluoroethoxy-benzovesamicol, a radiotracer for cholinergic neurons. J. Labelled Comp. Radiopharm. 33:583-591.
47. 125/123I]IPH: A radioiodinated analog of epibatidine for in vivo studies of nicotinic acetylcholine receptors. Synapse, 26:392-399.
48. Pappata, S., Tavitian, B., Traykov, L., et al. (1996) In vivo imaging of human cerebral acetylcholinesterase. J. Neurochem. 67:876-879.
49. Parsons, S.M., and Rogers, G.A. (1993) In vivo diagnostics for Alzheimer's disease based on the acetylcholine transporter. Ann. Rep. Med. Chem., 28:247-255.
50. Perry, E.K., Court, M.A., Piggott, M.A., and Perry, M.A. (1994) Cholinergic component in dementia and normal aging, B.C. Huppert F.A., O'Connor D.W., eds. Cambridge University Press, Cambridge, UK.
51. Roedler, H. (1980) Accuracy of internal dose calculations with special consideration of radiopharmaceuticals biokinetics. In Radiopharmaceutical Dosimetry Symposium. Oak Ridge National Laboratory: HHS-Publ (FDA), pp. 1-20.
52. Rogers, G.A., Parsons, S.M., Andersen, D.C., Nilsson, L.M., Bahr, B.A., Kornreich, W.D., Kaufman, R., Jacobs, R.S., and Kirtman, B. (1989) Synthesis, in vitro acetyl choline-storage-blocking activities, and biological properties of derivatives and anaologues of trans-2-(4-phenylpiperidino)cyclohexanol (vesamicol). J. Med. Chem., 32:1217.
53. Rogers, G.A., Kornreich, W.D., Hand, K., and Parsons, S.M. (1993a) Kinetic and equilibrium characterization of vesamicol receptor ligand complexes with picomolar dissociation constants. Mol. Pharmacol., 44:633-641.
54. 18F-Labelled vesamicol derivatives: Synthesis and preliminary in vivo small animal positron emission tomography. Nucl. Med. Biol., 21:219-230.
55. Roghani, A., Feldman, J., Kohan, S.A., Shirzadi, A., Gundersen, C.B., Brecha, N., and Edwards, R.H. (1994) Molecular cloning of a putative vesicular transporter for acetylcholine. Proc. Natl. Acad. Sci. USA, 91:10620-10624.
56. Ruberg, M., Mayo, W., Brice, A., Duykaerts, C., Hauw, J.J., Simon, H., LeMoal, M., and Agid, Y. (1990) Choline acetyl transferase activity and vesamicol binding in the temporal cortex of patients with Alzheimer's disease, Parkinson's disease, and rats with basal forebrain lesions. Neuroscience, 35:327-333.
57. Samuel, W., Terry, R.D., DeTeresa, R., et al. (1994) Clinical correlates of cortical and nucleus basalis pathology in Alzheimer's dementia. Arch. Neurol., 51:772-778.
58. Scheff, S.W., DeKosky, S.T., and Price, D.A. (1990) Quantitative assessment of cortical synaptic density in Alzheimer's disease. Neurobiol. Aging, 11:29-37.
59. Svennerholm, L., and Gottfries, C.-G. (1994) Membrane lipids, selectively diminished in Alzheimer's brains, suggest synapse loss as a primary event in early-onset form (type 1) and demyelination in late-onset form (type II). J. Neuroehem., 62:1039-1047.
60. Terry, R.D., Masliah, E., Salmon, D.P., Butters, N., DeTeresa, R., Hill, R., Hansen, L.A., and Katzman, R. (1991) Physical basis of cognitive alterations in Alzheimer's disease: Synaptic loss is the major correlate of cognitive impairment. Ann. Neurol., 30:572-580.
61. Tucek, S. (1988) Choline acetyltransferase and the synthesis of acetylcholine. In: Handbook of Experimental Pharmacology. V.P. Whittaker, ed. Springer Verlag, Berlin, pp. 125-165.
62. 3H]hemicholinium-3 in the rat brain: A potentially selective marker for presynaptic cholinergic sites. Life Sci. 35:2235-2243.
63. Villemagne, V.L., Horti, A., Scheffel, U., Ravert, H.T., Finley, P., London, E.D., Wagner, H.N., and Dannals, R.F. (1997) Imaging nicotinic acetylcholine receptors with fluorine-18-FPH, an epibatidine analog. J. Nucl. Med., 38:1737-1741.
64. Watson, E., Stabin, M., and Bolch, W. (1988) MIRDOSE2, Oak Ridge Associated Universities, Oak Ridge, TN.